CINECA IRIS Institutional Research Information System

ROLFO, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.480
EU - Europa 3.621
AS - Asia 2.107
SA - Sud America 195
AF - Africa 85
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.396
IT - Italia 913
CN - Cina 870
SG - Singapore 696
DK - Danimarca 522
DE - Germania 444
IE - Irlanda 416
SE - Svezia 327
FI - Finlandia 243
FR - Francia 241
BR - Brasile 169
KR - Corea 153
UA - Ucraina 111
VN - Vietnam 108
GB - Regno Unito 98
PL - Polonia 85
CA - Canada 63
AT - Austria 61
ID - Indonesia 51
HK - Hong Kong 48
IN - India 44
AU - Australia 43
NL - Olanda 41
JP - Giappone 32
BE - Belgio 31
SN - Senegal 30
TR - Turchia 24
ES - Italia 19
NG - Nigeria 15
CH - Svizzera 14
MX - Messico 14
IR - Iran 13
RU - Federazione Russa 13
TW - Taiwan 13
AR - Argentina 12
EG - Egitto 8
ET - Etiopia 8
UZ - Uzbekistan 8
GR - Grecia 7
IQ - Iraq 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
BD - Bangladesh 6
CO - Colombia 6
MA - Marocco 6
PT - Portogallo 6
TH - Thailandia 5
YE - Yemen 5
CI - Costa d'Avorio 4
EC - Ecuador 4
GH - Ghana 4
IL - Israele 4
LT - Lituania 4
PH - Filippine 4
CY - Cipro 3
CZ - Repubblica Ceca 3
PE - Perù 3
ZA - Sudafrica 3
DO - Repubblica Dominicana 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
LK - Sri Lanka 2
MY - Malesia 2
RO - Romania 2
RS - Serbia 2
UG - Uganda 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
GT - Guatemala 1
JM - Giamaica 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SI - Slovenia 1
SO - Somalia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
ZM - Zambia 1
Totale 12.540
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.155
Chandler 752
Beijing 500
Dublin 415
Santa Clara 407
Singapore 401
Fairfield 334
Houston 329
Torino 309
Ashburn 281
Woodbridge 226
Wilmington 169
Villeurbanne 167
Nyköping 157
Seattle 145
Princeton 127
Medford 124
Jacksonville 118
Cambridge 113
Columbus 112
Dearborn 108
Pisa 107
Warsaw 78
Dong Ket 76
Boston 60
Guangzhou 59
Turin 50
Boardman 47
Fremont 46
Jakarta 46
Vienna 45
Nuremberg 37
Hong Kong 33
Milan 30
Rome 29
Shanghai 29
Redwood City 28
Brussels 27
San Diego 26
Hefei 24
Helsinki 20
Nanjing 19
Phoenix 18
Toronto 18
New York 17
Nürnberg 17
Silver Spring 17
Shenyang 15
Xian 14
Giugliano in Campania 13
Norwalk 13
Des Moines 12
The Dalles 12
Wuhan 12
Los Angeles 11
Edmonton 10
Fuzhou 10
Nanchang 10
São Paulo 10
Taipei 10
Hangzhou 9
Kunming 9
Chengdu 8
Falls Church 8
Ottawa 8
Artvin 7
Berlin 7
Brisbane 7
Hyderabad 7
Lappeenranta 7
Upper Marlboro 7
Abuja 6
Eau Claire 6
London 6
Montreal 6
Newark 6
Pune 6
Sydney 6
Verona 6
Brasília 5
Buffalo 5
Chicago 5
Florence 5
Frankfurt am Main 5
Jinan 5
Napoli 5
Porto Alegre 5
Rio de Janeiro 5
Seoul 5
Zhengzhou 5
Zurich 5
Abidjan 4
Accra 4
Amsterdam 4
Bologna 4
Buenos Aires 4
Chennai 4
Collegno 4
Curitiba 4
Guayaquil 4
Totale 7.832
Salva come PNG Salva come JPEG
Nome #
Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia. 303
Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers 272
Feto-placental vascularization: A multifaceted approach. 269
JunB/Cyclin-D1 imbalance in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise. 267
Association of Low-Protein Supplemented Diets with Fetal Growth in Pregnant Women with CKD. 236
Istopatologia ed aspetti molecolari: espressione dell’alfa-smooth muscle actin (alfa-sma) in placente fisiologiche ed in placente complicate da Fetal Grewth Restriction (FGR) 232
Is It Possible to Differentiate Chronic Kidney Disease and Preeclampsia by means of New and Old Biomarkers? A Prospective Study 214
Is Helicobacter Pylori infection a risk factor for miscarriage? 205
NUOVA APPLICAZIONE TERAPEUTICA DI UN MEZZO CONDIZIONATO DA CELLULE STAMINALI MESENCHIMALI PLACENTARI 203
Differential expression of Tight Junction proteins in preeclamptic placentae 199
Characterization of Activator Protein-1 (AP-1) Family Gene Expression in Placental Mesenchymal Stem Cells derived from Normal and Preeclamptic Pregnancies. 195
Hepcidin Expression in Placentae from Preeclamptic Pregnancies with or without Fetal Growth Restriction 188
Anti-inflammatory and pro-angiogenic effects of placental mesenchymal stromal cells conditioned media on preeclamptic placental tissue. 184
Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls. 183
Abnormalities in Oxygen Sensing Define Early and LateOnset Preeclampsia as Distinct Pathologies 182
Placental expression of IGF-1 and IGFBP-3 in pregnancies complicated by fetal growth restriction 178
Helicobacter pylori and pregnancy-related disorders. 175
Infiammazione, NO e preeclampsia 173
Apelin protects the heart against ischemia-reperfusion injury via epidermal growth factor receptor (EGFR) transactivation 172
Characterization of Decoy Receptors D6 and DUFFY in Preeclamptic Placental Tissues. 167
Helicobacter pylori’s Virulence and Infection Persistence Define Preeclampsia complicated by Fetal Growth Retardation. 165
Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy 164
INDOLEAMINE-2,3-DEOXYGENASE (IDO1) OXYGEN-MEDIATED REGULATION IN NORMAL, PREECLAMPTIC AND CHRONIC KIDNEY DISEASE (CKD) PLACENTAE 164
Espressione placentare di IGF-1 e di IGFBP-3 in casi di preeclampsia con restrizione di crescita fetale 162
Espressione placentare di IGF-1 e IGFBP-3 in casi di preeclampsia con restrizione di crescita fetale 160
Experimental assessment of human umbilical vein compliance in physiological and IUGR pregnancies 160
Sensitivity and specificity of echography in the diagnosis of placental accretism in patients with diagnosis of placenta praevia 160
Over-expression of G1/S and G2/M negative cell cycle regulator p16, p18, p21, p27, LDOC1, PARP1 and Caspase3 in Preeclamptic (PE) Placenta-derived Mesenchymal Stromal Cells (PDMSCs). 158
Twin Pregnancy: A Model of Placental Adaptation 152
Twin pregnancy: A model of placental adaptation 151
Evidence for a role of TGF-beta1 in the expression and regulation of alpha-SMA in fetal growth restricted placentae. 150
The double life of MULE in preeclamptic and IUGR placentae. 145
PLACENTA DERIVED MESENCHYMAL STEM CELLS (PDMSCS) MODULATE HIF-1A, VEGF AND JUNB GENES IN OVARIAN CANCER CELLS. 145
Nucleated red blood cells in term fetuses: reference values using an automated analyzer. 144
Altered expression of G1/S phase cell cycle regulators in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise 142
A Single Sphingomyelin Species Promotes Exosomal Release of Endoglin into the Maternal Circulation in Preeclampsia 141
Severe IUGR pregnancies have increased placental endoglin levels: hypoxic regulation via TGFbeta3 138
Macrophage Migration Inhibitory Factor (MIF) In Fetoplacental Tissues From Preeclamptic Pregnancies With Or Without Fetal Growth Restriction. 137
PLACENTAL CONTRIBUTION TO FETAL NEUROLOGICAL DEVELOPMENT: ROLE OF PLACENTA-DERIVED MESENCHYMAL STROMAL CELLS (PDMSCS) IN PHYSIOLOGICAL AND PREECLAMPTIC PREGNANCIES 129
La Preeclampsia: dalla caratterizzazione clinico molecolare alla diagnosi precoce 123
Differential Expression of Vascular Endothelial Growth Factor (VEGF) and its Soluble Receptor sFlt-1 in Chronic Kidney Disease (CKD) and Preeclamptic Placentae. 123
Chronic gestational hypoxia accelerates ovarian aging and lowers ovarian reserve in next-generation adult rats 119
Placental Adaptation to Early-Onset Hypoxic Pregnancy and Mitochondria-Targeted Antioxidant Therapy in a Rodent Model 114
Preeclampsia (PE) or Chronic Kidney Disease (CKD): Are soluble Fms-like Tyrosine Kinase-1 (sFlt-1) and Placental Growth Factor (PlGF) Suitable Biomarkers for Differential Diagnosis? 113
Anti-inflammatory effect of Low Molecular Weight Heparin (LMWH) is mediated by Placental High Mobility Group Box 1 (HMGB1) Modulation: New Therapeutic Perspectives for Preeclampsia 112
Upcoming strategies in obstetrics: how the technology of clinical audit may reduce cesarean birth. 112
Effects of oxygen tension and dextran-shelled/2H,3H-decafluoropentane-cored oxygen-loaded nanodroplets on secretion of gelatinases and their inhibitors in term human placenta 111
Placental Chemokine Receptor D6 Is Functionally Impaired in Pre-Eclampsia 110
Fetal-Maternal Exposure to Endocrine Disruptors: Correlation with Diet Intake and Pregnancy Outcomes 110
Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes 106
In vivo mitochondria-targeted protection against uterine artery vascular dysfunction and remodelling in rodent hypoxic pregnancy 104
Helicobacter pylori seropositivity and gestational diabetes mellitus – A prospective cohort study. 104
Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo. 103
Chronic fetal hypoxia disrupts the peri-conceptual environment in next-generation adult female rats 103
Activating protein-1 family of transcription factors in the human placenta complicated by preeclampsia with and without fetal growth restriction 102
Pre-eclampsia or chronic kidney disease? The flow hypothesis. 99
Expression of Neurogenesis Markers by Normal and Preeclmaptic Placenta-Derived Mesenchymal Stem Cells (PDMSCs): New Insights into Fetal Neurological Development. 97
Hypoxia and iron imbalance impairs JMJD6-mediated histone demethylation of VHL in preeclampsia 97
The HMGB1/RAGE pro-inflammatory axis in the human placenta: Modulating effect of low molecular weight heparin 97
Role of Inflammatory Chemokines in Gestational Diabetes Pathogenesis 96
Is Renal Hyperfiltration Protective in Ckd-Stage 1 Pregnancies? A Step Forward Unraveling the Mystery of the Effect of Stage 1 Ckd on Pregnancy Outcomes. 94
Increased Production of Microphage migration Inhibitory Factor and other Pro-inflammatory Cytokines by Preeclamptic Placental Mesenchymal Stem Cells: New Insights into the Etiopathogenesis of Preeclampsia. 88
Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study. 88
Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus 87
Ultrasound-mediated oxygen delivery from chitosan nanobubbles 84
Characterization of DUFFY Decoy Receptor in Placentae from Pregnancies Complicated by both Preeclampsia and Gestational Diabetes 84
Role of the macrophage migration inhibitory factor in the pathophysiology of pre-eclampsia 81
Low Molecular Weight Heparin (LMWH) modulation of placental HMGB1/RAGE axis: novel understanding of Preeclampsia management. 80
A Novel Role for Factor Inhibiting HIF1 (FIH) in Regulating TGFbeta3 Expression in the Human Placenta 79
Pregnancy in Chronic Kidney Disease: Questions and answers in a changing panorama 79
Anticancer Activity of Placenta-derived Mesenchymal Stromal Cells on Epithelial Ovarian Cancer (EOC) 78
Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control Study 77
Effect of Placenta-Derived Mesenchymal Stromal Cells Conditioned Media on an LPS-Induced Mouse Model of Preeclampsia 77
New perspectives for prostate cancer treatment: in vitro inhibition of LNCaP and PC3 cell proliferation by amnion-derived mesenchymal stromal cells conditioned media. 76
Severe diabetic nephropathy in type 1 diabetes and pregnancy - a case series. 76
Alterazioni Dell’Apoptosi Placentare Nel Diabete Gestazionale Mellito (GDM): Ruolo di PARP-1 e Caspasi-3. 75
Increased Placental Anti‐Oxidant Response in Asymptomatic and Symptomatic COVID‐19 Third‐Trimester Pregnancies 75
Microbubble-mediated oxygen delivery to hypoxic tissues as a new therapeutic device 74
Sonographic evaluation of the fetal spine position and success rate of manual rotation of the fetus in occiput posterior position: A randomized controlled trial 74
Effect of Depressive Disorders and Their Pharmacological Treatment during Pregnancy on Maternal and Neonatal Outcome 73
Reticulocyte count and reticulocyte maturation profile in human umbilical cord blood from healthy newborns. 72
Biotechnology, Industry and Research in Piemonte from 1990 to 2003 : an update 68
The Placental Phenotype Adapts to Chronic Hypoxia and Mitochondria-Targeted Antioxidant (MitoQ) Therapy in Rat Pregnancy 68
Ceruloplasmin: Placental Defence Against Oxidative Stress 67
Risk of adverse pregnancy outcomes by pre-pregnancy Body Mass Index among Italian population: a retrospective population-based cohort study on 27,807 deliveries 66
Consecutive chorioangiomas in the same pregnancy: A clinical case and review of literature 66
A Novel Role for Von Hippel-Lindau (VHL) Protein in Regulating Trophoblast Cell Proliferation in Normal and Pathological Pregnancy 64
The placental phenotype adapts to chronic hypoxia and mitochondrial-targeted antioxidant (MitoQ) therapy in rat pregnancy. 63
Mcl-1 Ubiquitin Ligase E3 (MULE) is a Target for Hypoxia Inducible Factor-1alpha (HIF-1alpha) 59
IFPA Meeting 2011 workshop report III: Placental immunology; epigenetic and microRNA-dependent gene regulation; comparative placentation; trophoblast differentiation; stem cells. 59
Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction. 59
Complete blood counts (CBC) in healthy and small for gestational age fetuses 58
From Uterus to Brain: An Update on Epidemiology, Clinical Features, and Treatment of Brain Metastases From Gestational Trophoblastic Neoplasia 58
Bax deficiency causes intrauterine growth restriction and leads to altered labyrinthine vasculature 57
Characterization of Siah-1 Isoforms in Normal and Preeclamptic Placentae. 56
Placental glucose transporters and response to bisphenol a in pregnancies from of normal and overweight mothers 56
A CONDITIONED MEDIUM OBTAINED FROM PLACENTAL MESENCHYMAL STEM CELLS AND USE THEREOF IN THE THERAPEUTIC TREATMENT OF PREECLAMPSIA. 55
p18 Contributes to Aberrant Cyclin-D1 Expression in Preeclamptic Placental Mesenchymal Stromal Cells (PDMSCs) 51
IFPA Meeting 2013 Workshop Report I: diabetes in pregnancy, maternal dyslipidemia in pregnancy, oxygen in placental development, stem cells and pregnancy pathology. 51
La Placenta come fonte di Cellule Staminali: Nuove Prospettive in Medicina Rigenerativa. 49
Totale 12.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.544
article - articoli 0
book - libri 0
conference - conferenze 15.497
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020138 0 0 0 0 0 0 0 0 0 0 77 61
2020/20211.245 126 101 65 69 112 65 55 57 134 137 64 260
2021/20221.947 146 146 144 173 105 117 182 157 113 96 288 280
2022/20232.048 203 199 47 213 188 547 141 117 204 32 98 59
2023/2024822 114 182 34 32 32 64 23 69 2 52 94 124
2024/20251.984 27 163 154 234 585 124 63 151 288 168 27 0
Totale 13.077